Abstract

Abstract BACKGROUND The treatment options of breast conservation therapy (BCT) and immediate reconstruction for patients with carcinoma of the breast have not been adopted widely. The objectives of this study were to determine how often a second opinion on the local therapy of breast carcinoma changed patient management and to identify factors predictive of remaining at the second‐opinion site for therapy. METHODS Two hundred thirty‐one patients with intraductal carcinoma or Stage I and II breast carcinoma were reviewed retrospectively. At the time of the second opinion, patients completed a questionnaire regarding their initial surgical opinion and the reason for seeking consultation. RESULTS Only 46% of patients had a complete discussion of treatment options prior to the second opinion. The second opinion changed management in 54 patients (20.3%). The most common finding was eligibility for BCT in patients who were offered only mastectomy. Definitive local therapy occurred at the second‐opinion site in 65.8% of patients. The only predictors of remaining at the second‐opinion site were insurance type ( P = 0.008) and the patient's perception that options were not discussed at the initial opinion ( P < 0.001). CONCLUSIONS Second opinions provide useful information to patients and may change the management of their disease. They result in significant patient capture for an institution. Cancer 2002;94:889–94. © 2002 American Cancer Society. DOI 10.1002/cncr.10318

Keywords

MedicineSecond opinionMastectomyBreast carcinomaExpert opinionBreast cancerStage (stratigraphy)CarcinomaGeneral surgeryCancerSurgeryInternal medicineIntensive care medicinePathology

MeSH Terms

AdultAgedAged80 and overBreast NeoplasmsCarcinomaIntraductalNoninfiltratingDecision MakingFemaleHumansMiddle AgedPatient Care PlanningPatient Education as TopicReferral and ConsultationRetrospective Studies

Affiliated Institutions

Related Publications

Breast Cancer Treatment

Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct...

2019 JAMA 4488 citations

Publication Info

Year
2002
Type
article
Volume
94
Issue
4
Pages
889-894
Citations
42
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

42
OpenAlex
1
Influential
36
CrossRef

Cite This

Jennifer Clauson, Y. C. Hsieh, Simbi Acharya et al. (2002). Results of the Lynn Sage Second‐Opinion Program for local therapy in patients with breast carcinoma. Cancer , 94 (4) , 889-894. https://doi.org/10.1002/cncr.10318

Identifiers

DOI
10.1002/cncr.10318
PMID
11920455

Data Quality

Data completeness: 86%